Erratum: Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: Questionnaire validation (Journal of Oncology Pharmacy Practice (2008) vol. 14 (3) 10.1177/1078155208090624);Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: Questionnaire validation

Journal of Oncology Pharmacy Practice

Volumn 14, Issue 3, 2008, Pages 123-130

  Hanigan, Marie H ^a,b   dela Cruz, Brian L ^a   Thompson, David M ^b   Farmer, Kevin C ^b   Medina, Patrick J ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Chemotherapy; Concomitant medications; Drug interactions; Over the counter medications

Indexed keywords

ACETYLSALICYLIC ACID; ACTENOL; ALENDRONIC ACID; ALPHA TOCOPHEROL; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; ASCORBIC ACID; GUAIFENESIN; HERBACEOUS AGENT; HYDROCHLOROTHIAZIDE PLUS METOPROLOL; HYDROCODONE; IBUPROFEN; LEVOTHYROXINE; MELATONIN; METOPROLOL; MINERAL; NON PRESCRIPTION DRUG; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PANTOPRAZOLE; PARACETAMOL; PHOSPHATIDYLCHOLINE; POTASSIUM; PSEUDOEPHEDRINE; RANITIDINE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RISEDRONIC ACID; TAMSULOSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN; ZINC; PLANT MEDICINAL PRODUCT; PRESCRIPTION DRUG;

ADULT; AGED; ANALYTICAL ERROR; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; DRUG SELF ADMINISTRATION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SENSITIVITY AND SPECIFICITY; DIET SUPPLEMENTATION; DRUG UTILIZATION; MIDDLE AGED; NEOPLASM; REPRODUCIBILITY; SELF MEDICATION; STATISTICAL ANALYSIS; UTILIZATION REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DATA INTERPRETATION, STATISTICAL; DIETARY SUPPLEMENTS; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NONPRESCRIPTION DRUGS; PLANT PREPARATIONS; PRESCRIPTION DRUGS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF MEDICATION; VITAMINS;

EID: 58249089775     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/1078155208098836     Document Type: Erratum

References (28)

1. Richardson MA, Sanders T., Palmer JL, Greisinger A., Singletary SE Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology 2000; 18: 2505-14.
2. Navo MA, Phan J., Vaughan C., Palmer JL, Michaud L., Jones KL et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. Journal of Clinical Oncology 2004; 22: 671-7.
3. Goldstein MS, Brown ER, Ballard-Barbash R., Morgenstern H., Bastani R., Lee J. et al. The use of complementary and alternative medicine among california adults with and without cancer. Evid Based Complement Alternat Med 2005; 2: 557-65.
4. Riechelmann RP, Tannock IF, Wang L., Saad ED, Taback NA, Krzyzanowska MK Potential drug interactions and duplicate prescriptions among cancer patients. Journal of National Cancer Institute 2007; 99: 592-600.
5. Nicholas HG, Holoford MB Pharmacokinetics and pharmacodynamics: Rational dosing and the time course of drug action. In: Katzung BG, ed. Basic and clinical pharmacology. 9th edn, New York; Lange Medical Books/ McGraw-Hill, 2004; 34-50.
6. Biagini C., Bender V., Borde F., Boissel E., Bonnet MC, Masson MT et al. Cytochrome P450 expression-induction profile and chemically mediated alterations of the WIF-B9 cell line. Biol Cell 2006; 98: 23-32.
7. Michalets EL Update: Clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 1998; 18: 84-112.
8. Schroder H., Covas MI, Marrugat J., Vila J., Pena A., Alcantara M. et al. Use of a three-day estimated food record, a 72-hour recall and a food-frequency questionnaire for dietary assessment in a Mediterranean Spanish population. Clin Nutr 2001; 20: 429-37.
9. Guillard O., Fauconneau B., Olichon D., Dedieu G., Deloncle R. Hyperaluminemia in a woman using an aluminum-containing antiperspirant for 4 years. The American Journal of Medicine 2004; 117: 956-9.
10. Blumenthal M. Herbgram: Herb Sales Down 7.4 Percent in Mainstream Market. The Journal of the American Botanical Council 2005; 66: 63.
11. Sparreboom A., Cox MC, Acharya MR, Figg WD Herbal remedies in the United States: Potential adverse interactions with anticancer agents. Journal of Clinical Oncology 2004; 22: 2489-503.
12. Cassileth BR, Lucarelli CD Herb-Drug Interactions in Oncology. Hamilton, Ontario, BC Decker, 2003.
13. Kemm JR, Booth D. What is meant by validation. In: Kemm JR, Booth D. eds. Promotion of Healthier Eating: How to Collect and Use Information for Panning, Monitoring and Evaluation. London, HMSO, 1992; 63-73.
14. Smith PJ, Hadgu A. Sensitivity and specificity for correlated observations. Stat Med 1992; 11: 1503-9.
15. McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK Potential of chemotherapy-herb interactions in adult cancer patients. Support Care Cancer 2004; 12: 454-62.
16. Powell CB, Dibble SL, Dall'Era JE, Cohen I. Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer 2002; 12: 214-7.
17. Kao GD, Devine P. Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer 2000; 88: 615-9.
18. Eng J., Ramsum D., Verhoef M., Guns E., Davison J., Gallagher R. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther 2003; 2: 212-6.
19. Larson AM, Polson J., Fontana RJ, Davern TJ, Lalani E., Hynan LS et al. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364-72.
20. Lukiw WJ, Percy ME, Kruck TP Nanomolar aluminum induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. Journal of Inorganic Biochemistry 2005; 99: 1895-8.
21. Teicher BA, Schwartz JL, Holden SA, Ara G., Northey D. In vivo modulation of several anticancer agents by beta-carotene. Cancer Chemotherapy and Pharmacology 1994; 34: 235-41.
22. Lamson DW, Brignall MS Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999; 4: 304-29.
23. Conklin KA Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutr. Cancer 2000; 37: 1-18.
24. Weiger WA, Smith M., Boon H., Richardson MA, Kaptchuk TJ, Eisenberg DM Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med 2002; 137: 889-903.
25. Shord SS, Thompson DM, Krempl GA, Hanigan MH Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer. Anticancer Drugs 2006; 17: 207-15.
26. Klungel OH, de Boer A., Paes AH, Herings RM, Seidell JC, Bakker A. Influence of question structure on the recall of self-reported drug use. J Clin Epidemiol 2000; 53: 273-7.
27. Merlo J., Berglund G., Wirfalt E., Gullberg B., Hedblad B., Manjer J. et al. Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: An analysis of 16,060 women. Am J Epidemiol 2000; 152: 788-92.
28. Messerer M., Wolk A. Sensitivity and specificity of self-reported use of dietary supplements. Eur J Clin Nutr 2004; 58: 1669-71.